recombinant RNA vaccine (BioNTech SE)

N/A

Report date: 2025/06/11 11:02:18

Base Information

Drug Namerecombinant RNA vaccine (BioNTech SE)
Drug Alias NameRBL-001.3 RNA vaccine (BioNTech SE)gindameranRBL-001.1RBL-001.3
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunomodulatorsCancer/testis antigen 1 modulators
TargetsCancer/testis antigen 1
Therapy Area/IndicationsMelanomaNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesEuropeGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBiontech Se
China Registration ClassN/A

Develop Information

Active CompaniesBiontech Se
Inactive CompaniesN/A
Active IndicationsMelanomaNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A